There was no significant difference in the GEP score between BRAF-mutated and WT NSCLC groups, accompanied by similar IFN-γ signatures, T cell markers, and chemokines (Fig. 4A, B). The gene discussed is BRAF; the disease is non-small cell lung carcinoma.